Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports

被引：0
|
作者：
Ceresoli, Giovanni Luca [1 ]
Mannarino, Laura [2 ,3 ]
Paracchini, Lara [2 ,3 ]
Grosso, Federica [4 ]
机构：
[1] Humanitas Gavazzeni, Dept Med Oncol, Oncol Unit, Bergamo, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] IRCCS Humanitas Res Hosp, Lab Canc Pharmacol, Milan, Italy
[4] SS Antonio & Biagio Gen Hosp, Mesothelioma & Rare Canc Unit, Alessandria, Italy
来源：
CURRENT PROBLEMS IN CANCER: CASE REPORTS | 2025年 / 17卷
关键词：
PHASE-III; GLIOBLASTOMA;
D O I：
10.1016/j.cpccr.2024.100342
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] LONG-TERM SURVIVAL IN GLIOBLASTOMA PATIENTS AFTER TUMOR TREATING FIELDS (TTFIELDS) THERAPY
    Rulseh, Aaron
    Derner, Adam
    Sroubek, Jan
    Klener, Jan
    Vymazal, Josef
    NEURO-ONCOLOGY, 2020, 22 : 58 - 59
  • [2] TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN PATIENTS WITH GLIOBLASTOMA: LONG-TERM SURVIVAL RESULTS FROM TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER) STUDY
    Baehr, O.
    Tabatabai, G.
    Fietkau, R.
    Goldbrunner, R.
    Glas, M.
    NEURO-ONCOLOGY, 2024, 26
  • [3] Pemetrexed long-term maintenance therapy for advanced severe lung cancer with long-term progression-free survival: a case report
    Zhao, Weichao
    Zhu, Minli
    Wang, Ruijuan
    Tong, Zhaohui
    ANTI-CANCER DRUGS, 2023, 34 (05) : 686 - 689
  • [4] LONGTERM SURVIVAL AFTER TUMOR TREATING FIELDS (TTFIELDS) THERAPY
    Rulseh, A.
    Sroubek, J.
    Klener, J.
    Vymazal, J.
    NEURO-ONCOLOGY, 2017, 19 : 81 - 81
  • [5] Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma
    Guzman-Casta, Jordi
    Carrasco-CaraChards, Sonia
    Guzman-Huesca, Jorge
    Sanchez-Rios, Carla Paola
    Riera-Sala, Rodrigo
    Martinez-Herrera, Jose Fabian
    Pena-Mirabal, Erika Sagrario
    Bonilla-Molina, Diana
    Alatorre-Alexander, Jorge Arturo
    Martinez-Barrera, Luis Manuel
    Rodriguez-Cid, Jeronimo Rafael
    THORACIC CANCER, 2021, 12 (07) : 1014 - 1022
  • [6] Tumor treating fields (TTFields) therapy in patients with glioblastoma: Long-term survival results from TTFields in Germany in routine clinical care (TIGER) study.
    Baehr, Oliver
    Tabatabai, Ghazaleh
    Fietkau, Rainer
    Goldbrunner, Roland
    Glas, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Long-term Efficacy of Tumor Treating Fields (TTFields 150 kHz) in metastatic NSCLC: A Case Report
    Chmielewska, I.
    Wojcik-Superczynska, M.
    Milanowski, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S597 - S598
  • [8] Malignant pleural mesothelioma with long survival - case reports
    Cvok, T
    Radosavljevic, G
    Jakovic, R
    Cemerikic, V
    Milenkovic, B
    3RD INTERNATIONAL CONGRESS ON LUNG CANCER, 1998, : 329 - 332
  • [9] Management of tumor treating fields (TTFields) therapy-related skin adverse events in pleural mesothelioma: A single center experience of TTFields therapy concomitant with chemotherapy
    Grosso, Federica
    Delfanti, Sara
    Gallizzi, Giulia
    Marengo, Francesca
    Megna, Iacopo
    Bertolina, Carlotta
    Ceresoli, Giovanni Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Long Progression-free Survival by Pemetrexed Continuation Maintenance Therapy Following Cisplatin-based Chemotherapy in Malignant Pleural Mesothelioma
    Takeda, Takayuki
    Itano, Hideki
    Fukita, Shinichi
    Saitoh, Masahiko
    Takeda, Sorou
    INTERNAL MEDICINE, 2014, 53 (20) : 2347 - 2351
12345